Department of Research and Analysis, National Health Insurance Service Ilsan Hospital, 100 Ilsan-ro, Ilsandong-gu, Goyang-si, 10444, Republic of Korea.
Division of Cancer Control & Policy, National Cancer Control Institute, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si, 10408, Republic of Korea.
Int J Colorectal Dis. 2023 Aug 22;38(1):219. doi: 10.1007/s00384-023-04509-3.
The prevalence of diabetes is higher in patients with colorectal cancer, which is important because diabetes is recognized as a risk factor for increased mortality. This study investigated the impact of incident diabetes-related complications on all-cause five-year mortality in older aged colorectal cancer patients with diabetes.
The 2008 to 2019 National Health Insurance Service data on the elderly were used to identify patients with colorectal cancer aged 60 years or above diagnosed with type 2 diabetes mellitus. The outcome measure was all-cause five-year mortality. The main independent variable was incident status of diabetes-related complications using the Diabetes Complications Severity Index (DCSI). Survival analyses were performed using the Cox proportional hazards model, in addition to the calculation of risk differences. Subgroup analysis was conducted based on the type of complication and DCSI scores.
Among 1,312 individuals, 319 (24.3%) died within five years after one year of a cancer diagnosis. The risk of mortality was higher in patients with diabetes and cancer having incident diabetes-related complications (Hazard Ratio 1.29, 95% Confidence Interval 1.03-1.63). These tendencies were generally maintained regardless of the type of complication and DCSI scores.
The incidence of diabetes-related complications after cancer diagnosis was associated with an increased risk of all-cause five-year mortality in older patients with colorectal cancer and preexisting diabetes.
患有结直肠癌的患者糖尿病患病率更高,这一点很重要,因为糖尿病已被认为是增加死亡率的一个风险因素。本研究调查了在患有糖尿病的老年结直肠癌患者中,新发与糖尿病相关的并发症对全因五年死亡率的影响。
使用 2008 年至 2019 年国家健康保险服务机构针对老年人的数据,确定了年龄在 60 岁及以上、被诊断患有 2 型糖尿病的结直肠癌患者。主要结局指标是全因五年死亡率。主要的独立变量是使用糖尿病并发症严重程度指数(DCSI)评估的新发与糖尿病相关的并发症的情况。采用 Cox 比例风险模型进行生存分析,并计算风险差异。根据并发症的类型和 DCSI 评分进行亚组分析。
在 1312 名患者中,有 319 名(24.3%)在癌症诊断后一年的五年内死亡。患有糖尿病和癌症且新发与糖尿病相关的并发症的患者的死亡风险更高(风险比 1.29,95%置信区间 1.03-1.63)。无论并发症的类型和 DCSI 评分如何,这些趋势基本保持不变。
癌症诊断后新发与糖尿病相关的并发症与老年结直肠癌合并糖尿病患者的全因五年死亡率增加相关。